| 2026-03-12 | +13.6% | news | GlobeNewswire | Orchestra BioMed Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Update |
| 2026-01-13 | -11.2% | news | Seeking Alpha | Terumo Corporation (TRUMY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript |
| 2025-01-09 | +11.2% | news | Seeking Alpha | Terumo's Improving Growth Outlook Is Worth More Attention |
| 2025-01-09 | +11.2% | news | Seeking Alpha | Terumo's Improving Growth Outlook Is Worth More Attention - Seeking Alpha |
| 2025-11-12 | +11.1% | earnings | Seeking Alpha | Terumo Corporation (TRUMY) Q2 2026 Earnings Call Transcript |
| 2025-11-12 | +11.1% | news | Seeking Alpha | Terumo reports 1H results |
| 2024-08-08 | -10.3% | earnings | Seeking Alpha | Terumo reports Q1 results |
| 2025-02-14 | -9.7% | earnings | Seeking Alpha | Terumo Corporation (TRUMF) Q3 2025 Earnings Call Transcript |
| 2024-08-10 | +9.6% | earnings | Seeking Alpha | Terumo Corporation (TRUMF) Q1 2025 Earnings Call Transcript |
| 2026-02-13 | -9.5% | earnings | Seeking Alpha | Terumo reports Q3 results |
| 2026-02-13 | -9.5% | earnings | Seeking Alpha | Terumo Corporation (TRUMY) Q3 2026 Earnings Call Transcript |
| 2026-02-13 | -9.5% | earnings | Seeking Alpha | Terumo Corporation 2026 Q3 - Results - Earnings Call Presentation |
| 2025-11-15 | -8.2% | earnings | Seeking Alpha | Terumo Corporation 2026 Q2 - Results - Earnings Call Presentation |
| 2025-05-14 | +8.0% | earnings | Seeking Alpha | Terumo Corporation (TRUMF) Q4 2025 Earnings Call Transcript |
| 2025-05-14 | +8.0% | earnings | Seeking Alpha | Terumo GAAP EPS of Yen 78.99, revenue of Yen 1.04T |
| 2025-05-21 | -7.6% | news | Seeking Alpha | Terumo: Consistent Execution Continues To Drive Solid Growth Metrics |
| 2025-08-07 | -7.1% | earnings | Seeking Alpha | Terumo Corporation 2026 Q1 - Results - Earnings Call Presentation |
| 2025-08-07 | -7.1% | earnings | Seeking Alpha | Terumo Corporation (TRUMF) Q1 2026 Earnings Call Transcript |
| 2025-08-25 | +6.6% | M&A | Seeking Alpha | Terumo buys OrganOx in $1.5B deal |
| 2023-11-17 | +5.7% | earnings | Seeking Alpha | Terumo Corporation (TRUMF) Q2 2024 Earnings Call Transcript |
| 2026-04-15 | +4.4% | news | ACCESS Newswire | Terumo Corporation Joins the Healthcare Plastics Recycling Council |
| 2024-11-09 | +3.9% | earnings | Seeking Alpha | Terumo Corporation (TRUMF) Q2 2025 Earnings Call Transcript |
| 2024-02-07 | +2.9% | earnings | Seeking Alpha | Terumo Corporation 2023 Q3 - Results - Earnings Call Presentation |
| 2026-03-30 | -2.6% | expansion | Simply Wall St. | Did Terumo’s (TSE:4543) New Tata Elxsi Partnership and Bond Shelf Just Reframe Its Investment Narrative? |
| 2026-03-19 | +1.9% | expansion | PR Newswire | Tata Elxsi Announces the Launch of a Global Offshore Development Center (ODC) for Terumo Corporation |
| 2026-03-05 | +1.9% | news | PR Newswire | Terumo Blood and Cell Technologies introduces APAC C> Ecosystem Blueprint |
| 2024-01-17 | +1.9% | earnings | Seeking Alpha | Improved Revenue Growth Is Terumo's Next Major Target |
| 2026-04-14 | +1.4% | executive | PR Newswire | Caristo Diagnostics Appoints Stephen Deitsch as Chief Executive Officer |
| 2025-02-13 | -1.1% | earnings | Seeking Alpha | Terumo Corporation 2025 Q3 - Results - Earnings Call Presentation |
| 2025-02-13 | -1.1% | earnings | Seeking Alpha | Terumo GAAP EPS of 66.51, revenue of 772.2B |
| 2024-05-16 | +0.9% | earnings | Seeking Alpha | Terumo Corporation (TRUMY) Q4 2024 Earnings Call Transcript |
| 2024-02-08 | -0.9% | earnings | Seeking Alpha | Terumo says revenue for nine months ended December 31 was 682.95B |
| 2026-04-20 | +0.9% | news | GlobeNewswire | Drug-Eluting Stents - Global Market Trends, Developments and Investment Opportunities 2026-2034 |
| 2026-04-01 | -0.8% | executive | GlobeNewswire | Femasys Appoints John Canning as Chief Operating Officer to Drive Operational Execution and Advance Commercial Growth |
| 2025-04-25 | -0.8% | news | Stock Titan | SOAGY Stock Price, News & Analysis - Stock Titan |
| 2026-03-09 | -0.7% | news | GlobeNewswire | [Latest] Global Intravenous Infusion Pump Market Size/Share Worth USD 14.02 Billion by 2035 at a 7.6% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) |
| 2024-11-07 | +0.7% | earnings | Seeking Alpha | Terumo Corporation 2025 Q2 - Results - Earnings Call Presentation |
| 2024-11-07 | +0.7% | news | Seeking Alpha | Terumo reports 1H results |
| 2024-02-09 | -0.5% | earnings | Seeking Alpha | Terumo Corporation (TRUMF) Q3 2024 Earnings Call Transcript |
| 2026-04-23 | -0.4% | news | GlobeNewswire | Catheters Market Report 2025-2030, Profiles and Strategy Analysis of Leading Players - Abbott Laboratories, Boston Scientific, Medtronic, Terumo, and B. Braun |
| 2024-07-31 | -0.2% | news | Seeking Alpha | Terumo Gaining Share In Growth Markets, But Consistency Still A Question |
| 2025-08-28 | +0.1% | M&A | Seeking Alpha | Terumo Acquiring Its Way Into The Intriguing Organ Donation Market |
| 2025-08-28 | +0.1% | M&A | Seeking Alpha | Terumo Acquiring Its Way Into The Intriguing Organ Donation Market (OTCMKTS:TRUMF) - Seeking Alpha |